| pubmed-article:6574820 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6574820 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:6574820 | lifeskim:mentions | umls-concept:C0007131 | lld:lifeskim |
| pubmed-article:6574820 | lifeskim:mentions | umls-concept:C0014582 | lld:lifeskim |
| pubmed-article:6574820 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:6574820 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:6574820 | pubmed:dateCreated | 1983-8-11 | lld:pubmed |
| pubmed-article:6574820 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6574820 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6574820 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6574820 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6574820 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6574820 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6574820 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6574820 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6574820 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:6574820 | pubmed:issn | 0361-5960 | lld:pubmed |
| pubmed-article:6574820 | pubmed:author | pubmed-author:WittesR ERE | lld:pubmed |
| pubmed-article:6574820 | pubmed:author | pubmed-author:KelsenD PDP | lld:pubmed |
| pubmed-article:6574820 | pubmed:author | pubmed-author:HeelanR TRT | lld:pubmed |
| pubmed-article:6574820 | pubmed:author | pubmed-author:GrallaR JRJ | lld:pubmed |
| pubmed-article:6574820 | pubmed:author | pubmed-author:CasperE SES | lld:pubmed |
| pubmed-article:6574820 | pubmed:author | pubmed-author:KrisM GMG | lld:pubmed |
| pubmed-article:6574820 | pubmed:author | pubmed-author:KalmanL ALA | lld:pubmed |
| pubmed-article:6574820 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6574820 | pubmed:volume | 67 | lld:pubmed |
| pubmed-article:6574820 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6574820 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6574820 | pubmed:pagination | 591-2 | lld:pubmed |
| pubmed-article:6574820 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:6574820 | pubmed:meshHeading | pubmed-meshheading:6574820-... | lld:pubmed |
| pubmed-article:6574820 | pubmed:meshHeading | pubmed-meshheading:6574820-... | lld:pubmed |
| pubmed-article:6574820 | pubmed:meshHeading | pubmed-meshheading:6574820-... | lld:pubmed |
| pubmed-article:6574820 | pubmed:meshHeading | pubmed-meshheading:6574820-... | lld:pubmed |
| pubmed-article:6574820 | pubmed:meshHeading | pubmed-meshheading:6574820-... | lld:pubmed |
| pubmed-article:6574820 | pubmed:meshHeading | pubmed-meshheading:6574820-... | lld:pubmed |
| pubmed-article:6574820 | pubmed:meshHeading | pubmed-meshheading:6574820-... | lld:pubmed |
| pubmed-article:6574820 | pubmed:meshHeading | pubmed-meshheading:6574820-... | lld:pubmed |
| pubmed-article:6574820 | pubmed:meshHeading | pubmed-meshheading:6574820-... | lld:pubmed |
| pubmed-article:6574820 | pubmed:meshHeading | pubmed-meshheading:6574820-... | lld:pubmed |
| pubmed-article:6574820 | pubmed:year | 1983 | lld:pubmed |
| pubmed-article:6574820 | pubmed:articleTitle | Phase II trial of 4'-epi-doxorubicin in patients with non-small cell lung cancer. | lld:pubmed |
| pubmed-article:6574820 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6574820 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:6574820 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6574820 | lld:pubmed |
